Next Article in Journal
Effects of Caffeine on Myocardial Blood Flow: A Systematic Review
Previous Article in Journal
Vegetable Diversity, Injurious Falls, and Fracture Risk in Older Women: A Prospective Cohort Study
Open AccessArticle

Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum

1
Department of Pharmaceutical Sciences, University of Milan, Via Mangiagalli 25, 20133 Milan, Italy
2
CREA-Research Centre for Food and Nutrition, Via Ardeatina 546, 00100 Rome, Italy
*
Author to whom correspondence should be addressed.
Nutrients 2018, 10(8), 1082; https://doi.org/10.3390/nu10081082
Received: 27 July 2018 / Revised: 7 August 2018 / Accepted: 9 August 2018 / Published: 13 August 2018
Recent investigations have focused on food-derived peptides as novel natural inhibitors of dipeptidyl peptidase IV (DPP-IV), a new target for diabetes. This study aimed to optimize fast, sensitive, and cost-effective DPP-IV assays in situ on human intestinal Caco-2 cells and ex vivo on human serum. Both assays were applied to investigate the inhibitory activity of soy and lupin peptides. The best conditions for in situ DPP-IV activity in Caco-2 cells were obtained using 2-day cells and 50 µM Gly-Pro-AMC. Sitagliptin, used as reference inhibitor, showed a dose-dependent response with a 50% inhibition concentration (IC50) of 0.6 µM. A lower IC50 (0.2 µM) was obtained for sitagliptin on human serum incubated with the substrate for 24 h. Both assays were applied to assess the activity of Lup1 (LTFPGSAED) and Soy1 (IAVPTGVA) on DPP-IV. Lup1 and Soy1 inhibited DPP-IV in situ, with IC50 values of of 207.5 and 223.2 µM, respectively, and maintained their inhibitory activity ex vivo on circulating DPP-IV with a slightly lower potency. These assays can be used to characterize the DPP-IV inhibitory activity of food-derived molecules more accurately than in vitro biochemical tests. This combined approach also considers their effects on the circulating form of DPP-IV, correlated to metabolic diseases. View Full-Text
Keywords: anti-diabetic activity; bioactive peptides; dipeptidyl peptidase IV; glucose metabolism; sitagliptin anti-diabetic activity; bioactive peptides; dipeptidyl peptidase IV; glucose metabolism; sitagliptin
Show Figures

Graphical abstract

MDPI and ACS Style

Lammi, C.; Bollati, C.; Ferruzza, S.; Ranaldi, G.; Sambuy, Y.; Arnoldi, A. Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum. Nutrients 2018, 10, 1082.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop